Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q

View through CrossRef
Abstract Serum amyloid P component (SAP) was polymerized using the cleavable cross-linker 3,3’-dithio-bis-(sulfo-succinimidylpropionate) to study its interaction with the C system. Dimers and trimers, but no larger oligomers, were observed; the trimers retained native SAP immunoreactivity (except for one calcium-dependent epitope) without displaying neo-SAP epitopes. The SAP trimers bound strongly to C1q, at the level of the collagen-like region (CLR). SAP bound to synthetic C1q A chain peptides 14-26 and 76-92, and these peptides inhibited the binding of SAP trimers to the CLR. When incubated in dilute human serum, SAP trimers consumed total C and C4, but not alternative pathway, hemolytic activities. Consumption of C4 by SAP trimers was inhibited by C1q A chain peptide 14-26. Thus, SAP oligomers bind C1q and activate the classical C pathway via the collagen-like region of C1q, at sites located within residues 14-26 and/or 76-92 of the C1q A chain.
Title: Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q
Description:
Abstract Serum amyloid P component (SAP) was polymerized using the cleavable cross-linker 3,3’-dithio-bis-(sulfo-succinimidylpropionate) to study its interaction with the C system.
Dimers and trimers, but no larger oligomers, were observed; the trimers retained native SAP immunoreactivity (except for one calcium-dependent epitope) without displaying neo-SAP epitopes.
The SAP trimers bound strongly to C1q, at the level of the collagen-like region (CLR).
SAP bound to synthetic C1q A chain peptides 14-26 and 76-92, and these peptides inhibited the binding of SAP trimers to the CLR.
When incubated in dilute human serum, SAP trimers consumed total C and C4, but not alternative pathway, hemolytic activities.
Consumption of C4 by SAP trimers was inhibited by C1q A chain peptide 14-26.
Thus, SAP oligomers bind C1q and activate the classical C pathway via the collagen-like region of C1q, at sites located within residues 14-26 and/or 76-92 of the C1q A chain.

Related Results

CLINICAL AND SEROLOGICAL CORRELATES OF SERUM C1Q AND ANTI-C1Q ANTIBODIES IN SOUTH AFRICANS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
CLINICAL AND SEROLOGICAL CORRELATES OF SERUM C1Q AND ANTI-C1Q ANTIBODIES IN SOUTH AFRICANS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
OBJECTIVE: To investigate the prevalence and clinical correlates of serum C1q and anti-C1q antibody titres in black South Africans with systemic lupus erythematosus (SLE). METHODS:...
Gonococcal infection in a nonhuman host is determined by human complement C1q
Gonococcal infection in a nonhuman host is determined by human complement C1q
Human C1q displayed a dose-dependent protection of gonococcal cells (GC) from the bactericidal effect of newborn rat serum. All rat pups injected with C1q-preincubated GC developed...
The location of binding sites on C1q for DNA.
The location of binding sites on C1q for DNA.
Abstract Previous studies have suggested that C1q reacts with DNA via both the globular region of C1q (GR) and the collagen-like region of C1q (CLR). In this study, ...
C1q receptor on murine cells.
C1q receptor on murine cells.
Abstract Different cells and cell lines of murine origin were tested for their capacity to bind the C subcomponent C1q by using biotinylated human C1q and strepta...
High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway
High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway
Abstract We have recently found that intravenous immunoglobulin (IVIg) prevents deposition of C3 and C4 fragments onto antibody sensitized erythrocytes. To find out ...
High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway
High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway
We have recently found that intravenous immunoglobulin (IVIg) prevents deposition of C3 and C4 fragments onto antibody sensitized erythrocytes. To find out if such an effect result...
Aberrant expression of C1q, IL-6 and β-catenin in class VI lupus nephritis
Aberrant expression of C1q, IL-6 and β-catenin in class VI lupus nephritis
Abstract Background: complement component C1q, interleukin-6 (IL-6) and β-catenin have been implicated in the pathogenesis of lupus nephritis (LN). However, their correlat...

Back to Top